NECTIN4 and neoplasm: Our results demonstrate significantly higher and more heterogenous Nectin-4 expression, especially in the cytoplasm of the tumor samples, and indicate that Nectin-4 may serve as a diagnostic, prognostic, and therapeutic biomarker in LSCC.